From our founders to our medical leads, each expert plays a hands-on role in shaping the future of men’s health — one patient at a time. This regenerative therapy supports stronger, longer-lasting erections while improving overall penile health and performance naturally. Ideal for men who train hard, travel often or need an extra metabolic boost, this therapy complements your lifestyle and helps your body make the most of your effort. At Gameday we use B12 to support red blood cell and nerve health in men who feel fatigued or need a reliable vitality boost.
Esters of these compounds have been investigated in hypogonadal men for androgen replacement and eugonadal men as a potential male contraceptive (7α-methyl-19-norestosterone, MENT94,95; 7α-methyl-11 β-methyl-19-norestosterone, Dimethandrolone DMA96-98; and 11β-methyl-19-norestosterone, 11 β MNT98,99). Although 17alpha-alkylated androgens are not recommended for androgen replacement for hypogonadal men, there are modified androgens with higher potency then testosterone that have been tested in men. We describe here the use of agents other than testosterone for the treatment of hypogonadism. Higher number of testosterone pellets produced more consistent and longer maintenance of serum testosterone concentrations for 4 to 6 months.
With exogenous testosterone supplementation, the pulsatile release of gonadotropin-releasing hormone is blunted and the release of follicle-stimulating hormone and luteinizing hormone are depressed. In a randomized, placebo-controlled trial, Basaria et al. reported an increased risk of cardiovascular events in men randomized to TRT; however, this small cohort had a high prevalence of chronic disease. They should be monitored for increased symptoms, such as snoring while sleeping or fatigue.
Traditionally, testosterone replacement therapy has been thought of as something only a small percentage of the population need, if they have chronically low levels of testosterone. Another study found that TRT doesn’t increase the risk of prostate cancer, even after more than 15 years of treatment. At this time, it is unclear whether TRT increases the risk of prostate cancer or symptoms of benign prostatic hyperplasia. This treatment is called testosterone replacement therapy, or TRT.
44 A 1.62% AndroGel® is supplied as a pump where one actuation delivers 20.25 mg of testosterone.47,48 The pharmacokinetic profile and safety profile is similar to the 1% gel but the recommended starting dose is 40.5 mg or two actuations which is less than 50 mg recommended for the 1 % gel. The surface area of the skin to which the gel was applied had a modest effect on the bioavailability of the testosterone gel. The Food and Drug Administration (FDA) approved the first testosterone gel (AndroGel®) in 2003 as a new method of delivering testosterone. However, the permeation enhanced patches are a closed system with an enhancer; mild irritation at the application site occurs in over two thirds of patients and up to 10 to 15% of men discontinue treatment because of skin irritation. Testosterone is slowly released from transdermal patches providing a state level of testosterone over 24 hours.

Gender: Female

Social links